450
Views
12
CrossRef citations to date
0
Altmetric
Research Article

Macro- and microvascular function in habitually exercising systemic lupus erythematosus patients

, , , &
Pages 209-216 | Accepted 16 Sep 2013, Published online: 07 Jan 2014

References

  • Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997;145:408–15.
  • Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399–406.
  • El-Magadmi M, Bodill H, Ahmad Y, Durrington PN, Mackness M, Walker M, Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004;110:399–404.
  • Roman MJ, Devereux RB, Schwartz JE, Lockshin MD, Paget SA, Davis A, Arterial stiffness in chronic inflammatory diseases. Hypertension 2005;46:194–9.
  • Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis 2004;14:228–32.
  • Tanaka H, Safar ME. Influence of lifestyle modification on arterial stiffness and wave reflections. Am J Hypertens 2005;18:137–44.
  • Ayan C, Martin V. Systemic lupus erythematosus and exercise. Lupus 2007;16:5–9.
  • Turesson C, Matteson EL. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Curr Opin Rheumatol 2007;19:190–6.
  • Carvalho MR, Sato EI, Tebexreni AS, Heidecher RT, Schenkman S, Neto TL. Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Rheum 2005;53:838–44.
  • Barnes JN, Nualnim N, Sugawara J, Sommerlad SM, Renzi CP, Tanaka H. Arterial stiffening, wave reflection, and inflammation in habitually exercising systemic lupus erythematosus patients. Am J Hypertens 2011;24:1194–200.
  • Lima DS, Sato EI, Lima VC, Miranda F Jr, Hatta FH. Brachial endothelial function is impaired in patients with systemic lupus erythematosus. J Rheumatol 2002;29:292–7.
  • Piper MK, Raza K, Nuttall SL, Stevens R, Toescu V, Heaton S, Impaired endothelial function in systemic lupus erythematosus. Lupus 2007;16:84–8.
  • DeSouza CA, Shapiro LF, Clevenger CM, Dinenno FA, Monahan KD, Tanaka H, Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 2000;102:1351–7.
  • Ansar Ahmed S, Talal N. Importance of sex hormones in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois’ lupus erythematosus. Philadelphia, PA: Lea & Febiger, 1993:148–56.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271–7.
  • Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280–6.
  • Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10:141–6.
  • Giannattasio C, Failla M, Grappiolo A, Stella ML, Del Bo A, Colombo M, Fluctuations of radial artery distensibility throughout the menstrual cycle. Arterioscler Thromb Vasc Biol 1999;19:1925–9.
  • Hashimoto M, Akishita M, Eto M, Ishikawa M, Kozaki K, Toba K, Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 1995;92:3431–5.
  • Hartley CJ, and H. Tanaka. Assessment of macro- and micro-vascular function and reactivity. In: Naghavi M, editor. Asymptomatic atherosclerosis: pathophysiology, detection, and treatment. New York, NY: Humana Press. 2010:265–75.
  • Eskurza I, Monahan KD, Robinson JA, Seals DR. Effect of acute and chronic ascorbic acid on flow-mediated dilatation with sedentary and physically active human ageing. J Physiol 2004;556:315–24.
  • Corretti MC, Plotnick GD, Vogel RA. Technical aspects of evaluating brachial artery vasodilatation using high-frequency ultrasound. Am J Physiol 1995;268:H1397–404.
  • Vuilleumier P, Decosterd D, Maillard M, Burnier M, Hayoz D. Postischemic forearm skin reactive hyperemia is related to cardovascular risk factors in a healthy female population. J Hypertens 2002;20:1753–7.
  • Rosei EA, Rizzoni D, Castellano M, Porteri E, Zulli R, Muiesan ML, Media:lumen ratio in human small resistance arteries is related to forearm minimal vascular resistance. J Hypertens 1995;13:341–7.
  • Folkow B. Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? J Hypertens 1995;13:1546–59.
  • Pedrinelli R, Spessot M, Salvetti A. Reactive hyperemia during short-term blood flow and pressure changes in the hypertensive forearm. J Hypertens 1990;8:467–71.
  • Tanaka H, Reiling MJ, Seals DR. Regular walking increases peak limb vasodilatory capacity of older hypertensive humans: implications for arterial structure. J Hypertens 1998;16:423–8.
  • Jasperse JL, Seals DR, Callister R. Active forearm blood flow adjustments to handgrip exercise in young and older healthy men. J Physiol 1994;474:353–60.
  • Dhindsa M, Sommerlad SM, DeVan AE, Barnes JN, Sugawara J, Ley O, Interrelationships among noninvasive measures of postischemic macro- and microvascular reactivity. J Appl Physiol 2008;105:427–32.
  • Balsamo S, Santos-Neto LD. Fatigue in systemic lupus erythematosus: an association with reduced physical fitness. Autoimmun Rev 2011;10:514–18.
  • Bostrom C, Dupre B, Tengvar P, Jansson E, Opava CH, Lundberg IE. Aerobic capacity correlates to self-assessed physical function but not to overall disease activity or organ damage in women with systemic lupus erythematosus with low-to-moderate disease activity and organ damage. Lupus 2008;17:100–4.
  • Kiss E, Soltesz P, Der H, Kocsis Z, Tarr T, Bhattoa H, Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmun 2006;27:211–17.
  • Wright SA, O’Prey FM, Rea DJ, Plumb RD, Gamble AJ, Leahey WJ, Microcirculatory hemodynamics and endothelial dysfunction in systemic lupus erythematosus. Arterioscler Thromb Vasc Biol 2006;26:2281–7.
  • Aizer J, Karlson EW, Chibnik LB, Costenbader KH, Post D, Liang MH, A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus. Lupus 2009;18:235–42.
  • Cypiene A, Kovaite M, Venalis A, Dadoniene J, Rugiene R, Petrulioniene Z, Arterial wall dysfunction in systemic lupus erythematosus. Lupus 2009;18:522–9.
  • Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003;41:1281–6.
  • Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A. Antihypertensive drugs and reversing of endothelial dysfunction in hypertension. Curr Hypertens Rep 2000;2:64–70.
  • Eriksson K, Svenungsson E, Karreskog H, Gunnarsson I, Gustafsson J, Moller S, Physical activity in patients with systemic lupus erythematosus and matched controls. Scand J Rheumatol 2012;41:290–7.
  • Cooper DM, Radom-Aizik S, Schwindt C, Zaldivar F Jr. Dangerous exercise: lessons learned from dysregulated inflammatory responses to physical activity. J Appl Physiol 2007;103:700–9.
  • Haaland DA, Sabljic TF, Baribeau DA, Mukovozov IM, Hart LE. Is regular exercise a friend or foe of the aging immune system? A systematic review. Clin J Sport Med 2008;18:539–48.
  • Appel GB, Pirani CL, D’Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 1994;4:1499–515.
  • Meroni PL, Tincani A, Sepp N, Raschi E, Testoni C, Corsini E, Endothelium and the brain in CNS lupus. Lupus 2003;12:919–28.
  • Levy BI, Ambrosio G, Pries AR, Struijker-Boudier HA. Microcirculation in hypertension: a new target for treatment? Circulation 2001;104:735–40.
  • Granholm NA, Cavallo T. Prolonged circulation of immune complexes due to various altered immune functions contributes to nephritis in MRL/lpr mice. Clin Exp Immunol 1990;82:300–6.
  • Anania C, Norman M, Heimburger M, Gustafsson T, Jogestrand T, Hafstrom I, Microcirculation as determined by iontophoresis in SLE-patients and controls. Lupus 2012;21:815–20.
  • de Leeuw K, Blaauw J, Smit A, Kallenberg C, Bijl M. Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired. Lupus 2008;17:1010–17.
  • Bongard O, Miescher PA, Bounameaux H. Altered skin microcirculation in patients with systemic lupus erythematosus. Int J Microcirc Clin Exp 1997;17:184–9.
  • de Leeuw K, Graaff R, de Vries R, Dullaart RP, Smit AJ, Kallenberg CG, Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2007;46:1551–6.
  • Cracowski JL, Minson CT, Salvat-Melis M, Halliwill JR. Methodological issues in the assessment of skin microvascular endothelial function in humans. Trends Pharmacol Sci 2006; 27:503–8.
  • Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Prognostic significance of small-artery structure in hypertension. Circulation 2003;108:2230–5.
  • Egerer K, Feist E, Rohr U, Pruss A, Burmester GR, Dorner T. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000;9:614–21.
  • Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I. Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000;18:565–70.
  • Houssiau FA, Lefebvre C, Vanden Berghe M, Lambert M, Devogelaer JP, Renauld JC. Serum interleukin 10 titers in systemic lupus erythematosus reflect disease activity. Lupus 1995;4:393–5.
  • Sabry A, Sheashaa H, El-Husseini A, Mahmoud K, Eldahshan KF, George SK, Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine 2006;35:148–53.
  • Sloan RP, Shapiro PA, Demeersman RE, McKinley PS, Tracey KJ, Slavov I, Aerobic exercise attenuates inducible TNF production in humans. J Appl Physiol 2007;103:1007–11.
  • Mora S, Lee IM, Buring JE, Ridker PM. Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. J Am Med Assoc 2006;295: 1412–19.
  • Adamopoulos S, Parissis J, Kroupis C, Georgiadis M, Karatzas D, Karavolias G, Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. Eur Heart J 2001;22:791–7.
  • Tisi PV, Hulse M, Chulakadabba A, Gosling P, Shearman CP. Exercise training for intermittent claudication: does it adversely affect biochemical markers of the exercise-induced inflammatory response? Eur J Vasc Endovasc Surg 1997;14:344–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.